Literature DB >> 9445200

Hiccups with high dose dexamethasone administration: a case report.

R J Cersosimo1, M T Brophy.   

Abstract

BACKGROUND: A 59-year-old male developed intractable hiccups during monthly therapy with high dose dexamethasone for multiple myeloma. Hiccups would begin hours after his first dose and continue over the 4 days of therapy. He sought assistance after his attempt at home remedies failed and the hiccups became exhausting.
METHODS: The strong temporal relation between dexamethasone administration and the occurrence of hiccups indicated that dexamethasone was the cause of the patient's hiccups. Because he was responding to dexamethasone, the decision was made to continue therapy and to relieve his hiccups with metoclopramide.
RESULTS: Low dose oral metoclopramide allowed the patient to continue therapy without a recurrence of the hiccups.
CONCLUSIONS: Dexamethasone administration can result in intractable hiccups that persist for the duration of therapy. Low dose oral metoclopramide may prevent hiccups in patients in whom the discontinuation of dexamethasone therapy is not appropriate.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9445200     DOI: 10.1002/(sici)1097-0142(19980115)82:2<415::aid-cncr23>3.0.co;2-0

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  9 in total

1.  Case report: sexual intercourse as potential treatment for intractable hiccups.

Authors:  R Peleg; A Peleg
Journal:  Can Fam Physician       Date:  2000-08       Impact factor: 3.275

2.  Recurrence of exhausting hiccup in a patient treated with chemotherapy for metastatic colon cancer.

Authors:  D Errante; D Bernardi; A Bianco; N Zanatta; L Salvagno
Journal:  Gut       Date:  2005-10       Impact factor: 23.059

3.  Persistent hiccups induced by dexamethasone.

Authors:  J Ross; M Eledrisi; P Casner
Journal:  West J Med       Date:  1999-01

4.  Unilateral phrenic nerve plasy: a rare manifestation of vincristine neurotoxicity: correspondence.

Authors:  Kunihiko Moriya; Yosuke Kakisaka; Masaei Onuma; Yoji Sasahara; Shigeo Kure
Journal:  Indian J Pediatr       Date:  2014-03-22       Impact factor: 1.967

Review 5.  Perspectives on the Medical, Quality of Life, and Economic Consequences of Hiccups.

Authors:  Katharine Hendrix; David Wilson; M J Kievman; Aminah Jatoi
Journal:  Curr Oncol Rep       Date:  2019-12-19       Impact factor: 5.075

6.  Antiemetic Corticosteroid Rotation from Dexamethasone to Methylprednisolone to Prevent Dexamethasone-Induced Hiccup in Cancer Patients Treated with Chemotherapy: A Randomized, Single-Blind, Crossover Phase III Trial.

Authors:  Se-Il Go; Dong-Hoe Koo; Seung Tae Kim; Haa-Na Song; Rock Bum Kim; Joung-Soon Jang; Sung Yong Oh; Kyung Hee Lee; Soon Il Lee; Seong-Geun Kim; Lee Chun Park; Sang-Cheol Lee; Byeong-Bae Park; Jun Ho Ji; Seong Yoon Yi; Yun-Gyoo Lee; Jina Yun; Eduardo Bruera; In Gyu Hwang; Jung Hun Kang
Journal:  Oncologist       Date:  2017-07-07

7.  Treatment of dexamethasone-induced hiccup in chemotherapy patients by methylprednisolone rotation.

Authors:  Gyeong-Won Lee; Sung Yong Oh; Myoung Hee Kang; Jung Hun Kang; Se Hoon Park; In Gyu Hwang; Seong Yoon Yi; Young Jin Choi; Jun Ho Ji; Ha Yeon Lee; Eduardo Bruera
Journal:  Oncologist       Date:  2013-10-09

8.  Persistent Hiccups as an Atypical Presentation of SARS-CoV-2 Infection: A Systematic Review of Case Reports.

Authors:  Panagiotis Giannos; Konstantinos Katsikas Triantafyllidis; Georgios Geropoulos; Konstantinos S Kechagias
Journal:  Front Neurol       Date:  2022-04-04       Impact factor: 4.086

9.  Transient hiccups associated with oral dexamethasone.

Authors:  Mark E Peacock
Journal:  Case Rep Dent       Date:  2013-10-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.